ERCC1 and colorectal carcinoma: In contrast, Varma et al. (Asian; India) found no significant association between the C allele of the ERCC1 rs11615 SNP and response to CAPOX adjuvant therapy in 145 CRC patients (stages II–III) (OR = 0.50; 95% CI = 0.10–2.00; p = 0.300 for CT/CC vs. TT) [30].